James DArecca

Insider Reports History

Entity
Individual
Location
C/O Haemonetics Corporation, 125 Summer Street, Boston, MA
Signature
/s/ James C. D'Arecca by Christine Sacco Attorney-in-Fact pursuant to Power of Attorney dated July 5, 2023 on file with the Commission
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James DArecca:

Stock Role Class Num Shares Value Price $ Report Date Ownership
HAEMONETICS CORP EVP, Chief Financial Officer Common Stock 17.3K $1.66M $95.73 May 17, 2024 Direct
TherapeuticsMD, Inc. Chief Financial Officer Restricted Stock Units 434K $1.58M $3.64 Aug 10, 2021 Direct
Prestige Consumer Healthcare Inc. Director Common Stock, par value $0.01 per share 4.5K $315K $70.00 Aug 6, 2024 Direct
TherapeuticsMD, Inc. Chief Financial Officer Common Stock 124K $277K $2.24 Aug 12, 2021 Direct
HAEMONETICS CORP EVP, Chief Financial Officer Non-qualified Stock Option (Right to Buy) 9.76K May 17, 2024 Direct

Insider Reports Filed by James DArecca

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PBH Prestige Consumer Healthcare Inc. Aug 6, 2024 1 $0 4 Aug 7, 2024 Director
HAE HAEMONETICS CORP May 17, 2024 2 $0 4 May 21, 2024 EVP, Chief Financial Officer
HAE HAEMONETICS CORP May 15, 2024 2 -$73K 4 May 17, 2024 EVP, Chief Financial Officer
HAE HAEMONETICS CORP May 2, 2024 1 -$40.3K 4 May 6, 2024 EVP, Chief Financial Officer
PBH Prestige Consumer Healthcare Inc. Aug 1, 2023 1 $0 4 Aug 3, 2023 Director
PBH Prestige Consumer Healthcare Inc. Aug 1, 2023 0 $0 3 Aug 3, 2023 Director
HAE HAEMONETICS CORP May 15, 2023 3 -$31.1K 4 May 17, 2023 EVP, Chief Financial Officer
HAE HAEMONETICS CORP May 2, 2023 1 -$35.1K 4 May 4, 2023 EVP, Chief Financial Officer
HAE HAEMONETICS CORP May 16, 2022 2 $0 4 May 18, 2022 EVP, Chief Financial Officer
HAE HAEMONETICS CORP May 2, 2022 2 $0 4 May 4, 2022 EVP, Chief Financial Officer
HAE HAEMONETICS CORP Apr 11, 2022 0 $0 3 Apr 14, 2022 EVP, Chief Financial Officer
TXMD TherapeuticsMD, Inc. Aug 10, 2021 3 -$81.2K 4 Aug 12, 2021 Chief Financial Officer
TXMD TherapeuticsMD, Inc. Jul 1, 2021 2 $0 4 Jul 2, 2021 CFO